The Circadian System in Alzheimer’s Disease: Disturbances, Mechanisms, and Opportunities

Alzheimer's disease (AD) is a devastating neurodegenerative condition associated with severe cognitive and behavioral impairments. Circadian rhythms are recurring cycles that display periods of approximately 24 hours and are driven by an endogenous circadian timekeeping system centered on the suprachiasmatic nucleus of the hypothalamus. We review the compelling evidence that circadian rhythms are significantly disturbed in AD and that such disturbance is of significant clinical importance in terms of behavioral symptoms. We also detail findings from neuropathological studies of brain areas associated with the circadian system in postmortem studies, the use of animal models of AD in the investigation of circadian processes, and the evidence that chronotherapeutic approaches aimed at bolstering weakened circadian rhythms in AD produce beneficial outcomes. We argue that further investigation in such areas is warranted and highlight areas for future research that might prove fruitful in ultimately providing new treatment options for this most serious and intractable of conditions.

[1]  A. Coogan,et al.  DIURNAL, AGE, AND IMMUNE REGULATION OF INTERLEUKIN-1β AND INTERLEUKIN-1 TYPE 1 RECEPTOR IN THE MOUSE SUPRACHIASMATIC NUCLEUS , 2010, Chronobiology international.

[2]  N. Rawlings,et al.  Effects of neurotensin on discharge rates of rat suprachiasmatic nucleus neurons in vitro , 2001, Neuroscience.

[3]  S. Ancoli-Israel,et al.  Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women , 2011, Alzheimer's & Dementia.

[4]  S. Nam,et al.  Inflammation and Alzheimer’s disease , 2010, Archives of pharmacal research.

[5]  R. Kondratov,et al.  The circadian clock and pathology of the ageing brain , 2012, Nature Reviews Neuroscience.

[6]  A. Lewy Melatonin and human chronobiology. , 2007, Cold Spring Harbor symposia on quantitative biology.

[7]  W. Revelle,et al.  Circadian phase-shifting effects of nocturnal exercise in older compared with young adults. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[8]  S. Ancoli-Israel,et al.  CIRCADIAN RHYTHMS OF AGITATION IN INSTITUTIONALIZED PATIENTS WITH ALZHEIMER'S DISEASE , 2000, Chronobiology international.

[9]  J. T. Smith,et al.  Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer's disease , 2012, Experimental Neurology.

[10]  D. F. Swaab,et al.  The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia , 1985, Brain Research.

[11]  J. Thome,et al.  Haloperidol alters circadian clock gene product expression in the mouse brain , 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[12]  B. Baune,et al.  Neuroimmunomodulation in unipolar depression: a focus on chronobiology and chronotherapeutics , 2012, Journal of Neural Transmission.

[13]  R. Nelson,et al.  Altered temporal patterns of anxiety in aged and amyloid precursor protein (APP) transgenic mice , 2011, Proceedings of the National Academy of Sciences.

[14]  P. Scheltens,et al.  Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial , 2010, Trials.

[15]  J R Hodges,et al.  Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia. , 2004, Brain : a journal of neurology.

[16]  Thomas Reilly,et al.  Strong association of the rest-activity rhythm with well-being in demented elderly women. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[17]  S. Klaffke,et al.  Sundowning and circadian rhythm disorders in dementia. , 2006, Acta neurologica Belgica.

[18]  C. Wyse,et al.  Impact of aging on diurnal expression patterns of CLOCK and BMAL1 in the mouse brain , 2010, Brain Research.

[19]  C. McClung,et al.  Circadian rhythms and mood regulation: Insights from pre-clinical models , 2011, European Neuropsychopharmacology.

[20]  M. Mirmiran,et al.  Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients , 1997, Biological Psychiatry.

[21]  C. Marotta,et al.  Disruption of circadian regulation by brain grafts that overexpress Alzheimer beta/A4 amyloid. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Connor,et al.  Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[23]  P. Zandi,et al.  Apolipoprotein E Genotype and Mortality: Findings from the Cache County Study , 2005, Journal of the American Geriatrics Society.

[24]  Andrew N. Coogan,et al.  Chronotherapeutics and psychiatry: Setting the clock to relieve the symptoms , 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[25]  R. Foster,et al.  Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease , 2010, Nature Reviews Neuroscience.

[26]  A. McKee,et al.  Dorsomedial SCN neuronal subpopulations subserve different functions in human dementia. , 2008, Brain : a journal of neurology.

[27]  M. Okawa,et al.  Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia , 1994, Acta psychiatrica Scandinavica.

[28]  M. Hofman,et al.  Living by the clock: The circadian pacemaker in older people , 2006, Ageing Research Reviews.

[29]  B. Rusak,et al.  Localization of cholinergic neurons in the forebrain and brainstem that project to the suprachiasmatic nucleus of the hypothalamus in rat , 1993, The Journal of comparative neurology.

[30]  Christianna S. Williams,et al.  The Effect of Ambient Bright Light Therapy on Depressive Symptoms in Persons with Dementia , 2007, Journal of the American Geriatrics Society.

[31]  Gernot Riedel,et al.  EEG, activity, and sleep architecture in a transgenic AβPPswe/PSEN1A246E Alzheimer's disease mouse. , 2010, Journal of Alzheimer's disease : JAD.

[32]  W. Kamphorst,et al.  Decreased Vasopressin Gene Expression in the Biological Clock of Alzheimer Disease Patients With and Without Depression , 2000, Journal of neuropathology and experimental neurology.

[33]  Diane B. Boivin,et al.  Circadian Clock Gene Expression in Brain Regions of Alzheimer ’s Disease Patients and Control Subjects , 2011, Journal of biological rhythms.

[34]  Darren J Moore,et al.  Genetic mouse models of neurodegenerative diseases. , 2011, Progress in molecular biology and translational science.

[35]  J. Yesavage,et al.  The Relations among Caregiver Stress, “Sundowning” Symptoms, and Cognitive Decline in Alzheimer's Disease , 1992, Journal of the American Geriatrics Society.

[36]  J. Thome,et al.  Adult attention-deficit hyperactivity disorder is associated with alterations in circadian rhythms at the behavioural, endocrine and molecular levels , 2012, Molecular Psychiatry.

[37]  J. Yesavage,et al.  Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer’s disease: A role for cholinergic transmission , 2005, Neuroscience.

[38]  E. Stopa,et al.  Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. , 1999, Journal of neuropathology and experimental neurology.

[39]  D. Cardinali,et al.  Effect of Melatonin on Changes in Locomotor Activity Rhythm of Syrian Hamsters Injected with Beta Amyloid Peptide 25–35 in the Suprachiasmatic Nuclei , 2002, Cellular and Molecular Neurobiology.

[40]  M. Korte,et al.  The Secreted β-Amyloid Precursor Protein Ectodomain APPsα Is Sufficient to Rescue the Anatomical, Behavioral, and Electrophysiological Abnormalities of APP-Deficient Mice , 2007, The Journal of Neuroscience.

[41]  R. Dyck,et al.  Characterization of the 3xTg-AD mouse model of Alzheimer's disease: Part 1. Circadian changes , 2010, Brain Research.

[42]  LuAnn Etcher,et al.  Nonlinear indices of circadian changes in individuals with dementia and aggression , 2012, Psychiatry Research.

[43]  J. Waterhouse Circadian rhythms and cognition. , 2010, Progress in brain research.

[44]  Anna Wirz-Justice,et al.  Dawn–dusk simulation light therapy of disturbed circadian rest–activity cycles in demented elderly , 2003, Experimental Gerontology.

[45]  Philip Scheltens,et al.  Circadian rest—activity rhythm disturbances in alzheimer's disease , 1996, Biological Psychiatry.

[46]  R. D'Hooge,et al.  Age‐dependent cognitive decline in the APP23 model precedes amyloid deposition , 2003, The European journal of neuroscience.

[47]  L. Thal,et al.  A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. , 2003, Sleep.

[48]  M. Figueiro,et al.  Field measurements of light exposures and circadian disruption in two populations of older adults. , 2012, Journal of Alzheimer's disease : JAD.

[49]  Judy Mastick,et al.  Effect of morning bright light treatment for rest–activity disruption in institutionalized patients with severe Alzheimer's disease , 2005, International Psychogeriatrics.

[50]  S. Amir,et al.  A Circadian Rhythm in the Expression of PERIOD2 Protein Reveals a Novel SCN-Controlled Oscillator in the Oval Nucleus of the Bed Nucleus of the Stria Terminalis , 2004, The Journal of Neuroscience.

[51]  A. Wirz-Justice,et al.  Haloperidol Disrupts, Clozapine Reinstates the Circadian Rest–Activity Cycle in a Patient With Early-Onset Alzheimer Disease , 2000, Alzheimer disease and associated disorders.

[52]  Yaakov Stern,et al.  Disruptive behavior as a predictor in Alzheimer disease. , 2007, Archives of neurology.

[53]  D. Fish,et al.  Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer disease , 2004, Neurobiology of Aging.

[54]  P. Scheltens,et al.  Increased skin temperature in Alzheimer’s disease is associated with sleepiness , 2012, Journal of Neural Transmission.

[55]  S. Reppert,et al.  Coordination of circadian timing in mammals , 2002, Nature.

[56]  R. Galani,et al.  Modulation of photic resetting in rats by lesions of projections to the suprachiasmatic nuclei expressing p75 neurotrophin receptor , 2004, European Journal of Neuroscience.

[57]  C. Colwell,et al.  Phase-shifting mechanisms in the mammalian circadian system: new light on the carbachol paradox , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[58]  Andrew N. Coogan,et al.  Neuroimmunology of the circadian clock , 2008, Brain Research.

[59]  S. Endo,et al.  Effects of bright light on cognitive and sleep–wake (circadian) rhythm disturbances in Alzheimer‐type dementia , 2000, Psychiatry and clinical neurosciences.

[60]  J. Viña,et al.  Circadian System Functionality, Hippocampal Oxidative Stress, and Spatial Memory in the APPswe/PS1dE9 Transgenic Model of Alzheimer Disease: Effects of Melatonin or Ramelteon , 2012, Chronobiology international.

[61]  D F Swaab,et al.  Suprachiasmatic nucleus of the human brain: An immunocytochemical and morphometric analysis , 1996, The Anatomical record.

[62]  C. Schmidt,et al.  A time to think: Circadian rhythms in human cognition , 2007, Cognitive neuropsychology.

[63]  R. Silver,et al.  Minireview: The neuroendocrinology of the suprachiasmatic nucleus as a conductor of body time in mammals. , 2007, Endocrinology.

[64]  A. Satlin,et al.  Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer's disease. , 1992, The American journal of psychiatry.

[65]  J. Luxenberg,et al.  Melatonin and Bright‐Light Treatment for Rest–Activity Disruption in Institutionalized Patients with Alzheimer's Disease , 2008, Journal of the American Geriatrics Society.

[66]  M. Gorman,et al.  LIFESPAN DAILY LOCOMOTOR ACTIVITY RHYTHMS IN A MOUSE MODEL OF AMYLOID-INDUCED NEUROPATHOLOGY , 2010, Chronobiology international.

[67]  D. Cutler,et al.  Aberrant Gating of Photic Input to the Suprachiasmatic Circadian Pacemaker of Mice Lacking the VPAC2 Receptor , 2004, Journal of Neuroscience.

[68]  Dick F Swaab,et al.  Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. , 2008, JAMA.

[69]  S. Engelborghs,et al.  Altered circadian locomotor activity in APP23 mice: a model for BPSD disturbances , 2004, The European journal of neuroscience.

[70]  Steven A Brown,et al.  Peripheral Circadian Oscillators , 2008, Annals of the New York Academy of Sciences.

[71]  Sonia Ancoli-Israel,et al.  Increased Light Exposure Consolidates Sleep and Strengthens Circadian Rhythms in Severe Alzheimer's Disease Patients , 2003, Behavioral sleep medicine.

[72]  M. Binns,et al.  Meal delivery practices do not meet needs of Alzheimer patients with increased cognitive and behavioral difficulties in a long-term care facility. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[73]  F. Scheer,et al.  The suprachiasmatic nucleus functions beyond circadian rhythm generation , 2007, Neuroscience.

[74]  S. Allan,et al.  Age-related changes in core body temperature and activity in triple-transgenic Alzheimer’s disease (3xTgAD) mice , 2012, Disease Models & Mechanisms.

[75]  Kun Hu,et al.  Reduction of scale invariance of activity fluctuations with aging and Alzheimer's disease: Involvement of the circadian pacemaker , 2009, Proceedings of the National Academy of Sciences.

[76]  D. Swaab,et al.  VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease , 1995, Neurobiology of Aging.

[77]  D. Aarsland,et al.  Improvement in behavioral symptoms and advance of activity acrophase after short‐term bright light treatment in severe dementia , 2004, Psychiatry and clinical neurosciences.

[78]  M. Mirmiran,et al.  Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease , 1990, Biological Psychiatry.

[79]  G. Frisoni,et al.  Predictors of mortality and institutionalization in Alzheimer disease patients 1 year after discharge from an Alzheimer dementia unit. , 1995, Dementia.

[80]  S. Endo,et al.  Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia. , 2003, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[81]  B. C. Manning,et al.  Sundowning and circadian rhythms in Alzheimer's disease. , 2001, The American journal of psychiatry.

[82]  R. J. McDonald,et al.  Cholinergic depletion of the medial septum followed by phase shifting does not impair memory or rest–activity rhythms measured under standard light/dark conditions in rats , 2009, Brain Research Bulletin.

[83]  D. Swaab,et al.  Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer’s disease , 2007, Experimental Gerontology.

[84]  J. Luxenberg,et al.  Effect of timed bright light treatment for rest‐activity disruption in institutionalized patients with Alzheimer's disease , 2005, International journal of geriatric psychiatry.

[85]  U. Schibler,et al.  The mammalian circadian timing system: organization and coordination of central and peripheral clocks. , 2010, Annual review of physiology.

[86]  J. Gerstner,et al.  Circadian rhythms and memory formation , 2010, Nature Reviews Neuroscience.

[87]  E. Zee,et al.  The cholinergic system, circadian rhythmicity, and time memory , 2011, Behavioural Brain Research.

[88]  Chadi Touma,et al.  Activity changes and marked stereotypic behavior precede A β pathology in TgCRND8 Alzheimer mice , 2006, Neurobiology of Aging.

[89]  Chaur-Jong Hu,et al.  Expression of inducible nitric oxide synthase (iNOS) and period 1 (PER1) clock gene products in different sleep stages of patients with cognitive impairment , 2010, Journal of Clinical Neuroscience.

[90]  M. Korte,et al.  The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[91]  Anna Wirz-Justice,et al.  Biological rhythm disturbances in mood disorders , 2006, International clinical psychopharmacology.

[92]  A. McKee,et al.  Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration. , 2001, Archives of general psychiatry.